Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Vomiting 27Nausea 20Neoplasms 8Breast Neoplasms 6Lymphoma 3Stomach Neoplasms 2Rectal Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Leukemia 2Hematologic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Weight Loss 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Sarcoma 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Melanoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Inflammatory Breast Neoplasms 1Hematologic Diseases 1Glioma 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 240Rituximab 187fludarabine phosphate 129Etoposide 110Peripheral Blood Stem Cell Transplantation 108Mycophenolic Acid 94Filgrastim 91Melphalan 90Whole-Body Irradiation 88fludarabine 80Busulfan 80Tacrolimus 71Cytarabine 66Cyclosporine 66Radiotherapy 62Methotrexate 53Antilymphocyte Serum 53Granulocyte Colony-Stimulating Factor 51Vincristine 49Carmustine 48Doxorubicin 41Prednisone 37Thiotepa 33Bendamustine Hydrochloride 32Bortezomib 30Methylprednisolone 29Dexamethasone 28Stem Cell Transplantation 27thymoglobulin 26ibritumomab tiuxetan 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Non-Hodgkin × Palonosetron × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT01018758 2009-11-25

NHLPal

Gruppo Italiano Studio Linfomi

Phase 2 Completed
86 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡